D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHS
1601
DELISTED
Chicos FAS, Inc.
CHS
| $4.3M | 0.01% |
1,008,319
+522,672
| +108% | +$2.9M |
|
1602
CALL
Ecolab
ECL
$78.6B
| $4.29M | 0.01% |
+24,300
| New | +$3.95M |
|
1603
CALL
Royal Caribbean
RCL
$86.1B
| $4.29M | 0.01% |
37,400
+11,800
| +46% | +$1.34M |
|
1604
PUT
Microchip Technology
MCHP
$40.7B
| $4.27M | 0.01% |
103,000
-3,000
| -3% | -$124K |
|
1605
e.l.f. Beauty
ELF
$4.85B
| $4.26M | 0.01% |
402,081
+249,458
| +163% | +$2.22M |
|
1606
Helen of Troy
HELE
$649M
| $4.26M | 0.01% |
+36,742
| New | +$4.24M |
|
|
CNACU
1607
DELISTED
Constellation Alpha Capital Corp. Unit
CNACU
| $4.24M | 0.01% |
450,000
| – | – |
|
|
COHR
1608
CALL
DELISTED
Coherent Inc
COHR
| $4.24M | 0.01% |
29,900
+3,200
| +12% | +$405K |
|
1609
CALL
Marriott Vacations Worldwide
VAC
$3.35B
| $4.24M | 0.01% |
45,300
+824
| +2% | +$74K |
|
1610
Enel Chile
ENIC
$6.29B
| $4.23M | 0.01% |
816,817
+29,957
| +4% | +$156K |
|
|
CJ
1611
DELISTED
C&J Energy Services, Inc.
CJ
| $4.22M | 0.01% |
271,655
+151,000
| +125% | +$2.44M |
|
|
Y
1612
DELISTED
Alleghany Corp
Y
| $4.2M | 0.01% |
6,862
+1,470
| +27% | +$919K |
|
1613
Jacobs Solutions
J
$15.7B
| $4.19M | 0.01% |
67,396
-231,594
| -77% | -$13M |
|
|
EXPR
1614
DELISTED
Express, Inc.
EXPR
| $4.18M | 0.01% |
48,835
-20,052
| -29% | -$2.02M |
|
1615
Insteel Industries
IIIN
$593M
| $4.18M | 0.01% |
199,764
+158,600
| +385% | +$3.49M |
|
1616
Coherus Oncology
CHRS
$227M
| $4.18M | 0.01% |
306,274
-71,899
| -19% | -$959K |
|
1617
8x8 Inc
EGHT
$262M
| $4.17M | 0.01% |
206,655
-292,660
| -59% | -$5.72M |
|
1618
PUT
Bath & Body Works
BBWI
$4.02B
| $4.17M | 0.01% |
187,158
-163,284
| -47% | -$3.59M |
|
1619
Terreno Realty
TRNO
$7.65B
| $4.17M | 0.01% |
99,213
-13,995
| -12% | -$559K |
|
|
THCBU
1620
DELISTED
Tuscan Holdings Corp. Unit
THCBU
| $4.17M | 0.01% |
+400,000
| New | +$4.08M |
|
|
CSLT
1621
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $4.17M | 0.01% |
1,111,311
+497,605
| +81% | +$1.58M |
|
1622
MidCap Financial Investment
MFIC
$796M
| $4.16M | 0.01% |
274,596
+29,741
| +12% | +$446K |
|
1623
PUT
Owens Corning
OC
$11.2B
| $4.16M | 0.01% |
88,200
+3,100
| +4% | +$152K |
|
1624
PUT
Lumen
LUMN
$6.76B
| $4.14M | 0.01% |
345,000
-160,000
| -32% | -$2.22M |
|
|
AUY
1625
DELISTED
Yamana Gold, Inc.
AUY
| $4.13M | 0.01% |
1,585,275
+1,134,277
| +252% | +$2.94M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.